Big Pharma Doubles Down on China
While many foreign businesses are scaling back in China, U.S. pharmaceutical giant Eli Lilly is going against the grain with a string of new investments. Eli Lilly officials pose during an expansion ceremony held at the company’s site in Suzhou, October 11 …